Luteolin 7-O-β-D-Glucoside (L7G) is a highly relevant flavonoid glycoside found in many medicinal plants, widely recognized for its robust antioxidant, anti-inflammatory, and potential neuroprotective properties. Research indicates that the specific glycosylation at the C7 position significantly impacts its bioavailability, solubility, and ultimately, its pharmacological activity compared to the aglycone luteolin. High-purity L7G is therefore crucial for rigorous functional validation and drug development. The traditional method of obtaining L7G, primarily through plant extraction, yields mixtures with low purity and significant batch variability, complicating downstream development. Creative Biolabs overcomes this via highly controlled Enzymatic Biocatalysis, using a specific Flavone 7-O-β-D-Glucosyltransferase (F7GT) as the catalyst. This process is fundamentally a highly efficient and selective biochemical reaction:

Substrates: The reaction requires two key components: the aglycone substrate, luteolin (the target molecule to be modified), and the sugar donor, typically uridine diphosphate glucose (UDP-glucose), which provides the β-D-glucose moiety.
Catalyst: The F7GT enzyme is the key to specificity, which is meticulously engineered and overexpressed in our facility to ensure high activity. F7GT recognizes the luteolin structure and, critically, only catalyzes the transfer of the glucose unit from UDP-glucose to the hydroxyl group located at the C7 position of the luteolin molecule.
The Reaction: The F7GT binds both substrates in its active site, facilitates the transfer reaction, and releases the two products: the desired L7G and the byproduct uridine diphosphate (UDP).

Fig. 1 Common structural formulas of luteolin-type compounds. (OA Literature) Fig.1 The basic structure of luteolin-type compounds.¹

Find Your Perfect Solution - Inquire Now

The Advanced Enzymatic L7G Production Service

Creative Biolabs' service is engineered to overcome the inherent limitations of traditional L7G procurement, providing structurally precise material essential for advanced biological research and formulation studies. We reduce the variability associated with plant extraction and the side-product generation common in chemical synthesis. A clear, step-by-step process ensures transparency and high-quality results from initial inquiry to final delivery, facilitating seamless project integration for our clients.

Aspect	Details & Outcomes
Required Starting Materials	Target specification Substrate and enzymes Application context
Key Steps	Reaction design and pilot study: Optimization of buffer system, temperature, pH, and substrate/donor concentration (luteolin and UDP-glucose) for maximum conversion and yield. Scaled-up biocatalysis: Executing the enzymatic reaction under controlled conditions. Downstream purification: Utilizing chromatography and selective precipitation techniques to isolate L7G and remove unconverted substrates and F7GT enzyme. Quality control: Comprehensive testing (HPLC, NMR, MS) to confirm structural identity and purity.
Final Deliverables	Purified L7G Comprehensive analytical report Synthesis protocol summary
Estimated Timeframe	The typical timeframe for this service ranges from 8 to 14 weeks, depending on the requested quantity and the need for sourcing complex substrates or high-standard quality documentation.

Fig.2 The production workflow of L7G. (Creative Biolabs AI) Fig.2 The production process of L7G.

Key Advantages of Creative Biolabs' Enzymatic Synthesis

Exceptional Regiospecificity
The F7GT enzyme precisely directs the glucose moiety to the C7-hydroxyl group of Luteolin, avoiding unwanted C3' or C4' glycosylation isomers common in chemical synthesis.

High Purity and Safety
Our biocatalytic process is inherently cleaner than chemical methods, avoiding harsh solvents and resulting in non-toxic, contaminant-free material suitable for advanced research and sensitive formulation.

Cost-Effective Scalability
The high efficiency of the F7GT catalyst and our robust purification protocols make large-scale production more economical compared to tedious, low-yielding extraction or multi-step chemical routes.

Application

Pharmaceutical R&D: L7G, as a drug prodrug or active ingredient, is used to develop drugs for treating anti-inflammatory, anti-allergic, and cardiovascular diseases. Studies have shown its significant potential in inhibiting the release of inflammatory factors and protecting neurons. Custom services provide high-purity raw materials for preclinical studies.
Cosmeceuticals: L7G is used in skincare products as a natural anti-inflammatory and whitening agent. It effectively inhibits the activity of enzymes related to melanin synthesis and alleviates UV-induced skin damage, making it suitable for serums or creams targeting sensitive skin repair and anti-photoaging.
Standard materials: L7G provides qualitative and quantitative standards for analytical chemistry and quality control. In the quality identification of medicinal materials (such as honeysuckle and chrysanthemum), custom-made high-purity L7G samples are essential tools to ensure accurate test results and establish industry standards.

Review Your Options with Us- Inquire Now

Published Data

This research explores the therapeutic potential of the flavonoid luteolin-7-O-glucoside (LUT-7G or L7G) in mitigating vascular inflammation and preventing atherosclerosis. Using human umbilical vein endothelial cells (HUVECs) and a keratinocyte model for chronic inflammation, the study investigates how this natural compound influences molecular signaling pathways linked to cardiovascular and skin diseases. The findings indicate that L7G effectively suppresses the STAT3 pathway, reduces the production of harmful reactive oxygen species (ROS), and inhibits the proliferation of cells involved in arterial plaque formation. Overall, the literature highlights L7G as a promising bioactive agent that protects the endothelium through its dual ability to modulate gene expression and decrease the accumulation of lipids associated with vascular damage.

Fig. 3 Inflammatory gene expression regulated by L7G and analysis. (OA Literature) Fig.3 L7G processes and analyzes the expression of inflammation-related genes under regulatory control.¹

FAQs

Q: Why should I choose enzymatic synthesis over sourcing L7G from plant extracts?

A: Plant extracts suffer from low yield, high batch variability, and the presence of numerous impurities and flavonoid isomers. Our enzymatic process guarantees high purity and structural verification of L7G, eliminating the costly and time-consuming purification steps required for advanced research and high-grade material.

Q: What type of luteolin starting material do I need to provide, and what is the typical cost structure?

A: We manage the procurement of high-purity luteolin substrate as part of the service, or you may supply your own. The cost is primarily determined by the target quantity, required purity, and the complexity of the analytical verification needed. We offer highly competitive pricing compared to the true cost of in-house chemical or extractive purification.

Q: What precautions should be taken when using L7G in cell culture or in vivo studies?

A: Given its high purity, our L7G minimizes the risk of confounding results from impurities. However, as with all flavonoid compounds, solubility in aqueous media can be a factor. We recommend optimizing the solvent vehicle and concentration to ensure accurate dosing and cellular uptake. Our specialists can provide solubility recommendations based on your application.

Customer Review

Purity and Consistency
"Using Creative Biolabs' custom L7G production in our pharmacokinetic studies has significantly improved the reliability of our ADME data. The batch-to-batch consistency is unmatched by any commercial extract we've used."- Quality Director, J**n A.

Structural Verification
"The detailed NMR and mass spec data provided with the L7G confirmed the exact 7-O-glycoside structure, eliminating weeks of in-house verification efforts and allowing us to move faster into our mechanistic assays."- Technical Supervisor, P**l B.

Scalable Supply
"We transitioned from a complex, non-scalable chemical synthesis to Creative Biolabs' enzymatic method, immediately securing a reliable supply of high-quality L7G for our advanced formulation work. It saved us significant resources and streamlined our scale-up."- Senior Researcher, M**y C.

Extended Services

Custom Glucosyltransferase Engineering

For novel glycosylation targets beyond luteolin, we offer custom enzyme design and development services to produce highly specific glycosyltransferases.

High-Quality Small Molecule Synthesis

We offer custom synthesis services for various types of compounds, and we adhere to strict quality standards.

Advanced Analytical and Structural Elucidation Services

Our ISO-certified laboratory provides high-resolution NMR, mass spectrometry, and purity analysis for all your compounds.

Creative Biolabs: Your Partner in Precise Biomolecule Production

Creative Biolabs is dedicated to advancing therapeutic research by providing high-purity, structurally verified biomolecules via cutting-edge enzymatic biocatalysis. Our custom L7G production service delivers the purity, specificity, and scale required to move your project forward with confidence. Please contact us to inquire about detailed project scoping.

Reference

De Stefano, Alessandro et al. "Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside." International Journal of Molecular Sciences vol. 22,3 1321. 28 Jan. 2021. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/ijms22031321

For Research Use Only.

Related Services

Online Inquiry